1
|
Liu YH, Lin YS, Sie YY, Wang CC, Chang CI, Hou WC. Vitisin B, a resveratrol tetramer from Vitis thunbergii var. taiwaniana, ameliorates impaired glucose regulations in nicotinamide/streptozotocin-induced type 2 diabetic mice. J Tradit Complement Med 2023; 13:479-488. [PMID: 37693102 PMCID: PMC10491982 DOI: 10.1016/j.jtcme.2023.05.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2022] [Revised: 05/03/2023] [Accepted: 05/30/2023] [Indexed: 09/12/2023] Open
Abstract
Background and aim In Taiwan, Vitis thunbergii var. taiwaniana (VTT) is used in traditional medicine and as a local tea. VTT rich in resveratrol and resveratrol oligomers have been reported to exhibit anti-obesity and anti-hypertensive activities in animal models; however, no studies have investigated type 2 diabetes mellitus (T2DM) treatments. This study aimed to investigate the anti-T2DM effects of resveratrol tetramers isolated from the VTT in nicotinamide/streptozotocin (STZ)-induced Institute of Cancer Research (ICR) mice. Experimental procedure The oral glucose tolerance test (OGTT) was used to imitate postprandial blood glucose (BG) regulations in mice by pre-treatment with VTT extracts, resveratrol tetramers of vitisin A, vitisin B, and hopeaphenol 30 min before glucose loads. Vitisin B (50 mg/kg) was administered to treat T2DM-ICR mice once daily for 28 days to investigate its hypoglycemic activity. Results and conclusion Mice pre-treated with VTT-S-95EE, or vitisin B (100 mg/kg) 30-min before glucose loading showed significant reductions (P < 0.001) in the area under the curve at 120-min (BG-AUC0-120) than those without pre-treatment with VTT-S-95 E E or vitisin B. Vitisin B-treated T2DM mice showed hypoglycemic activities via a reduction in plasma dipeptidyl peptidase (DPP)-IV activities to maintain insulin actions and differed significantly than those of untreated T2DM mice (P < 0.05), and also reduced BG-AUC0-120 and insulin-AUC0-120 in the OGTT.These in vivo results showed that VTT containing vitisin B would be beneficial for developing nutraceuticals and/or functional foods for glycemic control in patients with T2DM, which should be investigated further.
Collapse
Affiliation(s)
- Yuh-Hwa Liu
- Department of General Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan
- Division of Gastroenterology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, 111, Taiwan
| | - Yin-Shiou Lin
- Graduate Institute of Pharmacognosy, Taipei Medical University, Taipei, 110, Taiwan
| | - Yi-Yan Sie
- Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei, Taiwan
| | - Ching-Chiung Wang
- Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei, Taiwan
- School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, 110, Taiwan
| | - Chi-I Chang
- Department of Biological Science and Technology, National Pingtung University of Science and Technology, Pingtung, 912, Taiwan
| | - Wen-Chi Hou
- Graduate Institute of Pharmacognosy, Taipei Medical University, Taipei, 110, Taiwan
| |
Collapse
|
2
|
Rajab E, Keogh MB, Laiva AL, Al Hannan F, Fateel M, Abdulwahab F, Al Madhoob F, AlHamer B, Ghazzal SY, Dawaishan A, Mahdi S, Qareeballa A, Almosawi SM, Falamarzi F, ElMusharaf K, Kamal A. Gum Arabic supplementation prevents loss of learning and memory through stimulation of mitochondrial function in the hippocampus of type 2 diabetic rats. J Funct Foods 2021. [DOI: 10.1016/j.jff.2021.104757] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
3
|
Pereira ACM, de Oliveira Carvalho H, Gonçalves DES, Picanço KRT, de Lima Teixeira dos Santos AVT, da Silva HR, Braga FS, Bezerra RM, de Sousa Nunes A, Nazima MTST, Cerqueira JG, Taglialegna T, Teixeira JM, Carvalho JCT. Co-Treatment of Purified Annatto Oil ( Bixa orellana L.) and Its Granules (Chronic ®) Improves the Blood Lipid Profile and Bone Protective Effects of Testosterone in the Orchiectomy-Induced Osteoporosis in Wistar Rats. Molecules 2021; 26:4720. [PMID: 34443306 PMCID: PMC8399955 DOI: 10.3390/molecules26164720] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2021] [Revised: 07/28/2021] [Accepted: 07/30/2021] [Indexed: 01/14/2023] Open
Abstract
This study aimed to evaluate and compare the effects of co-treatment with purified annatto oil (PAO) or its granules (GRA, Chronic®) with that of testosterone on the orchiectomy-induced osteoporosis in Wistar rats. After surgery, rats were treated from day 7 until day 45 with testosterone only (TES, 7 mg/kg, IM) or TES + PAO or GRA (200 mg/kg, p.o.). The following parameters were evaluated: food/water intake, weight, HDL, LDL, glucose, triglycerides (TG), total cholesterol (TC), alkaline phosphatase levels, blood phosphorus and calcium contents, femur weight, structure (through scanning electron microscopy), and calcium content (through atomic absorption spectrophotometry). Our results show that orchiectomy could significantly change the blood lipid profile and decrease bone integrity parameters. Testosterone reposition alone could improve some endpoints, including LDL, TC, bone weight, and bone calcium concentration. However, other parameters were not significantly improved. Co-treatment with PAO or GRA improved the blood lipid profile and bone integrity more significantly and improved some endpoints not affected by testosterone reposition alone (such as TG levels and trabeculae sizes). The results suggest that co-treatment with annatto products improved the blood lipid profile and the anti-osteoporosis effects of testosterone. Overall, GRA had better results than PAO.
Collapse
Affiliation(s)
- Arlindo César Matias Pereira
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
| | - Helison de Oliveira Carvalho
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
- Programa de Pós-Graduação em Inovação Farmacêutica, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil
| | - Danna Emanuelle Santos Gonçalves
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
| | - Karyny Roberta Tavares Picanço
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
| | - Abrahão Victor Tavares de Lima Teixeira dos Santos
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
| | - Heitor Ribeiro da Silva
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
| | - Francinaldo Sarges Braga
- Laboratório de Absorção Atômica e Bioprospecção, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (F.S.B.); (R.M.B.)
| | - Roberto Messias Bezerra
- Laboratório de Absorção Atômica e Bioprospecção, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (F.S.B.); (R.M.B.)
| | - Alessandro de Sousa Nunes
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
| | - Maira Tiyomi Sacata Tongo Nazima
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
| | - Júlia Gomes Cerqueira
- Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil; (J.G.C.); (T.T.)
| | - Talisson Taglialegna
- Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil; (J.G.C.); (T.T.)
| | - Janayra Maris Teixeira
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
| | - José Carlos Tavares Carvalho
- Laboratório de Pesquisa em Fármacos, Departamento de Ciências Biológicas e da Saúde, Colegiado de Farmácia, Universidade Federal do Amapá, Macapá 68902-280, AP, Brazil; (A.C.M.P.); (H.d.O.C.); (D.E.S.G.); (K.R.T.P.); (A.V.T.d.L.T.d.S.); (H.R.d.S.); (A.d.S.N.); (M.T.S.T.N.); (J.M.T.)
- Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil; (J.G.C.); (T.T.)
| |
Collapse
|
4
|
Silva JYGD, Rodrigues PAS, Paim RTT, Holanda MO, Lima CLS, Lira SM, de Freitas TV, Vieira IGP, Mendes FNP, Marques MMM, Guedes MIF. Chemical characterization of p-hydroxycinnamic diesters extracted from Copernicia prunifera and attenuation of biomarkers in C57BL/6J diabetic mice. FOOD BIOSCI 2021. [DOI: 10.1016/j.fbio.2021.100961] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
5
|
Santos Rodrigues AP, Faria E Souza BS, Alves Barros AS, de Oliveira Carvalho H, Lobato Duarte J, Leticia Elizandra Boettger M, Barbosa R, Maciel Ferreira A, Maciel Ferreira I, Fernandes CP, Cesar Matias Pereira A, Tavares Carvalho JC. The effects of Rosmarinus officinalis L. essential oil and its nanoemulsion on dyslipidemic Wistar rats. J Appl Biomed 2020; 18:126-135. [PMID: 34907765 DOI: 10.32725/jab.2020.016] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2019] [Accepted: 11/03/2020] [Indexed: 11/05/2022] Open
Abstract
Dyslipidemias are lipid metabolism alterations that cause increased levels of serum lipoprotein, cholesterol, and triglycerides. These alterations are associated with a higher incidence of cardiovascular diseases and are a risk factor for atherosclerosis development. This study aimed to evaluate the effect of Rosmarinus officinalis essential oil (EORO, 100 mg/kg) and its nanoemulsion (NEORO, 500 µg/kg) on Triton and coconut saturated-fat-induced (CSF) dyslipidemias using Wistar rats. The phytochemical evaluation of EORO performed by gas chromatography-mass spectroscopy (GC-MS) revealed 1,8-cineole (33.70%), camphor (27.68%), limonene (21.99%), and α-pinene (8.13%) as its major compounds. Triton-induced dyslipidemia significantly increased total cholesterol, LDL, and triglycerides levels. On the other hand, the groups treated with EORO and NEORO had significantly reduced total cholesterol, LDL, and triglycerides compared to the group treated only with Triton. Similar results were observed on the positive control treated with simvastatin. Dyslipidemia induced with coconut saturated-fat (CSF) caused abdominal fat gain, hypercholesterolemia, hypertriglyceridemia, increased LDL levels, and atherogenesis in the aorta. In contrast, the groups treated with EORO, NEORO, and simvastatin had significantly reduced hypercholesterolemia and hypertriglyceridemia, reduced abdominal fat gain, and absence of atherogenesis in the vascular endothelium. Overall, in the Triton-induced dyslipidemia model, EORO treatment had superior values than NEORO's (and simvastatin), although the differences were not too high, while in the CSF model, the values were mixed. In this manner, our results show an anti-dyslipidemic and anti-atherogenic activity effect by EORO and NEORO.
Collapse
Affiliation(s)
- Ana Paula Santos Rodrigues
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Curso de Farmacia, Laboratorio de Pesquisa em Farmacos, Macapa, Amapa, Brasil
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Programa de Pos-graduacao em Ciencias Farmaceuticas, Macapa, Amapa, Brasil
| | - Belmira Silva Faria E Souza
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Curso de Farmacia, Laboratorio de Pesquisa em Farmacos, Macapa, Amapa, Brasil
| | - Albenise Santana Alves Barros
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Curso de Farmacia, Laboratorio de Pesquisa em Farmacos, Macapa, Amapa, Brasil
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Programa de Pos-graduacao em Inovacao Farmaceutica, Macapa, Amapa, Brasil
| | - Helison de Oliveira Carvalho
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Curso de Farmacia, Laboratorio de Pesquisa em Farmacos, Macapa, Amapa, Brasil
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Programa de Pos-graduacao em Inovacao Farmaceutica, Macapa, Amapa, Brasil
| | - Jonatas Lobato Duarte
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Curso de Farmacia, Laboratorio de Pesquisa em Farmacos, Macapa, Amapa, Brasil
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Programa de Pos-graduacao em Ciencias Farmaceuticas, Macapa, Amapa, Brasil
| | - Mehl Leticia Elizandra Boettger
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Programa de Pos-graduacao em Ciencias Farmaceuticas, Macapa, Amapa, Brasil
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Curso de Farmacia, Laboratorio de Bioquimica e Citologia Clinica, Macapa, Amapa, Brasil
| | - Robson Barbosa
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Programa de Pos-graduacao em Ciencias Farmaceuticas, Macapa, Amapa, Brasil
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Curso de Farmacia, Laboratorio de Bioquimica e Citologia Clinica, Macapa, Amapa, Brasil
| | - Adriana Maciel Ferreira
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Curso de Farmacia, Laboratorio de Pesquisa em Farmacos, Macapa, Amapa, Brasil
| | - Irlon Maciel Ferreira
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Programa de Pos-graduacao em Ciencias Farmaceuticas, Macapa, Amapa, Brasil
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Programa de Pos-graduacao em Inovacao Farmaceutica, Macapa, Amapa, Brasil
- Universidade Federal do Amapa, Curso de Quimica, Laboratorio de Biocatalise e Biotransformacao em Quimica Organica, Macapa, Amapa, Brasil
| | - Caio Pinho Fernandes
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Programa de Pos-graduacao em Ciencias Farmaceuticas, Macapa, Amapa, Brasil
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Curso de Farmacia, Laboratorio de Nanobiotecnologia Fitofarmaceutica, Macapa, Amapa, Brasil
| | - Arlindo Cesar Matias Pereira
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Curso de Farmacia, Laboratorio de Pesquisa em Farmacos, Macapa, Amapa, Brasil
| | - Jose Carlos Tavares Carvalho
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Curso de Farmacia, Laboratorio de Pesquisa em Farmacos, Macapa, Amapa, Brasil
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Programa de Pos-graduacao em Ciencias Farmaceuticas, Macapa, Amapa, Brasil
- Universidade Federal do Amapa, Departamento de Ciencias Biologicas e da Saude, Programa de Pos-graduacao em Inovacao Farmaceutica, Macapa, Amapa, Brasil
| |
Collapse
|
6
|
Ab Rahman NS, Abdul Majid FA, Abd Wahid ME, Ismail HF, Tap FM, Zainudin AN, Zainol SN, Mohammad MA. Molecular docking analysis and anti-hyperglycaemic activity of Synacinn™ in streptozotocin-induced rats. RSC Adv 2020; 10:34581-34594. [PMID: 35514405 PMCID: PMC9058594 DOI: 10.1039/d0ra04664g] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2020] [Accepted: 08/31/2020] [Indexed: 11/21/2022] Open
Abstract
Synacinn™ is a standardized polyherbal supplement formulated from Cinnamomum zeylanicum Blume, Curcuma zanthorrhiza Roxb., Syzygium polyanthum (Wight) Walp., Orthosiphon stamineus Benth. and Andrographis paniculata (Burm.f.) Nees. It is designed for the synergistic treatment of diabetes mellitus and its complications. Although the beneficial effects are yet to be verified scientifically, it is traditionally used to improve general health in patients with diabetes. This study aimed to evaluate the anti-hyperglycemic effects of Synacinn™ in a streptozotocin-induced type 1 diabetes rat model. Initially, Synacinn™ was used for in vivo acute oral toxicity tests and 14 day repeated dose toxicity tests to determine the toxicity levels. An efficacy study of Synacinn™ was carried out via the oral administration of 10, 50, 100, 250, and 250 (b.i.d.) mg kg−1 doses to streptozotocin-induced diabetic rats. After 28 days, blood serum was collected to measure the fasting blood glucose, triglyceride, cholesterol, alanine aminotransferase, alkaline phosphatase, creatinine, and uric acid levels. The liver, kidney, and pancreas structures were histopathologically analyzed. In silico binding interaction studies of five phytochemicals in Synacinn™ identified via HPLC with glucokinase were performed using molecular docking analysis. The results showed that although no mortality was observed during the acute oral toxicity tests, notable damage to the liver and kidney occurred during the 14 day repeated dose testing at Synacinn™ levels of 600 mg kg−1 and 2000 mg kg−1. Treatment with 250 mg kg−1 (b.i.d.) Synacinn™ of the streptozotocin-induced type 1 diabetic rats significantly (p < 0.05) improved the fasting blood glucose (59%), triglyceride (58%), cholesterol (47%), alanine aminotransferase (60%), alkaline phosphatase (90%), and creatinine (32%) levels. Synacinn™ also improved the relative weights of liver (35%), kidney (36%), and pancreatic (36%) tissue. Histological analysis showed improvements in the conditions of the central vein of the liver, the kidney Bowman's capsule and glomerulus, and the pancreatic islets of Langerhans. HPLC analysis of a standardized extract identified five active phytochemicals: andrographolide (17.36 mg g−1), gallic acid (11.5 mg g−1), curcumin (2.75 mg g−1), catechin (3.9 mg g−1), and rosmarinic acid (5.54 mg g−1). Molecular docking studies with glucokinase showed that andrographolide yields the highest binding energy (−12.1 kcal mol−1), followed by catechin (−10.2 kcal mol−1), rosmarinic acid (−8.6 kcal mol−1), curcumin (−7.8 kcal mol−1), and gallic acid (−5.6 kcal mol−1). These current findings suggest that Synacinn™ at a dose of 250 mg kg−1 was non-toxic to rats. A twice-daily 250 mg kg−1 dose of Synacinn™ is an effective anti-hyperglycemic agent, lowering blood glucose, triglyceride, and cholesterol levels, and assisting the recovery of organ impairment caused by streptozotocin in type 1 diabetic rats. Synacinn™, a standardized polyherbal supplement, was shown to improve hyperglycemic conditions and related complications in STZ-induced rats.![]()
Collapse
Affiliation(s)
- Nur Syukriah Ab Rahman
- Institute of Marine Biotechnology, Universiti Malaysia Terengganu 21030 Malaysia .,Faculty of Chemical Engineering, Universiti Teknologi Mara Bukit Besi 23200 Dungun Terengganu Malaysia
| | | | | | - Hassan Fahmi Ismail
- Institute of Marine Biotechnology, Universiti Malaysia Terengganu 21030 Malaysia
| | - Fatahiya Mohamed Tap
- Faculty of Chemical Engineering, Universiti Teknologi Mara Bukit Besi 23200 Dungun Terengganu Malaysia
| | - Ain Nabihah Zainudin
- Institute of Marine Biotechnology, Universiti Malaysia Terengganu 21030 Malaysia .,Proliv Life Sciences Sdn Bhd D-1-16, Residensi Bistaria, Jalan Ulu Kelang, Taman Ukay Bistari 68000 Ampang Selangor Malaysia
| | - Siti Nurazwa Zainol
- Institute of Marine Biotechnology, Universiti Malaysia Terengganu 21030 Malaysia .,Proliv Life Sciences Sdn Bhd D-1-16, Residensi Bistaria, Jalan Ulu Kelang, Taman Ukay Bistari 68000 Ampang Selangor Malaysia
| | | |
Collapse
|
7
|
Xiang X, Xiang Y, Jin S, Wang Z, Xu Y, Su C, Shi Q, Chen C, Yu Q, Song C. The hypoglycemic effect of extract/fractions from Fuzhuan Brick-Tea in streptozotocin-induced diabetic mice and their active components characterized by LC-QTOF-MS/MS. J Food Sci 2020; 85:2933-2942. [PMID: 32794200 DOI: 10.1111/1750-3841.15373] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2020] [Revised: 05/22/2020] [Accepted: 06/18/2020] [Indexed: 01/07/2023]
Abstract
Fuzhuan Brick-Tea is a postfermented product with the hypoglycemic effect, which is prepared from the leaves of Camellia sinensis var. sinensis. However, the material basis associated with the hypoglycemic effect was not clear. The present research was designed to explore the hypoglycemic effect of extract/fractions from Fuzhuan Brick-Tea in streptozotocin-induced type II diabetic mice. Then an ultra-high pressure liquid chromatography along with quadrupole time of flight mass spectrometry was used to analyze the phytochemicals in Fuzhuan Brick-Tea fractions. As a result, the hypoglycemic and hypolipidemic effects were evidently observed from the serum biochemical indexes and liver pathological examination in type II diabetic mice. In addition, there were total of 20 major components including eight lysophosphatidylcholines (Lyso-PCs), five fatty acids, and seven novel theophylline derivatives tentatively identified in the active fraction from water extract. Therefore, these components were assumed to contribute partly to the hypoglycemic effect of Fuzhuan Brick-Tea. These findings also give the evidence that the Lyso-PCs, fatty acids, and novel theophylline derivatives in Fuzhuan Brick-Tea may provide benefits in ameliorating disorders of glucose and lipid metabolism. PRACTICAL APPLICATION: This study suggests that the Lyso-PCs, fatty acids, and novel theophylline derivatives in Fuzhuan Brick-Tea may provide benefits in ameliorating disorders of glucose and lipid metabolism. It can be taken as a beneficial diet additive or nutraceutical.
Collapse
Affiliation(s)
- Xingliang Xiang
- College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, China
| | - Yi Xiang
- Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Shuna Jin
- State Key Laboratory of Environmental Health School of Public Health Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Zhiqiang Wang
- Mogon Golden Fiower Tea Technology Co. Ltd., Changsha, Hunan, China
| | - Yiqiang Xu
- Mogon Golden Fiower Tea Technology Co. Ltd., Changsha, Hunan, China
| | - Chao Su
- College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, China
| | - Qingxin Shi
- College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, China
| | - Cheng Chen
- College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, China
| | - Qingsong Yu
- Department of Otolaryngology Union Hospital Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Chengwu Song
- College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, China
| |
Collapse
|
8
|
Keita H, dos Santos CBR, Ramos MM, Padilha EC, Serafim RB, Castro AN, Amado JRR, da Silva GM, Ferreira IM, Giuliatti S, Carvalho JCT. Assessment of the hypoglycemic effect of Bixin in alloxan-induced diabetic rats: in vivo and in silico studies. J Biomol Struct Dyn 2020; 39:1017-1028. [DOI: 10.1080/07391102.2020.1724567] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- Hady Keita
- Laboratory of Drugs Discovery, Department of Biological Sciences and Health, Federal University of Amapá, Macapá, Brazil
- Division of Post-Grade, University of the Sierra, Ixtlán de Juárez, México
| | - Cleydson Breno Rodrigues dos Santos
- Laboratory of Drugs Discovery, Department of Biological Sciences and Health, Federal University of Amapá, Macapá, Brazil
- Laboratory of Modeling and Computational Chemistry, Department of Biological Sciences and Health, Federal University of Amapa, Macapá, Brazil
| | - Matheus Mercês Ramos
- Research Group Biocatalysis and Apllied Organic Synthesis, Federal University of Amapa, Macapá, Brazil
| | - Elias Carvalho Padilha
- Department of Natural Active Principles and Toxicology, Faculty of Pharmaceutical Sciences, São Paulo State University, Araraquara, Brazil
| | - Rodolfo Bortolozo Serafim
- Department of Cellular and Molecular Biology, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil
| | - Andres Navarrete Castro
- Laboratory of Pharmacology of Natural Products, Faculty of Chemistry, Department of Pharmacy, Universidad Autonoma Nacional de Mexico, Ciudad de Mexico, Mexico
| | - Jesus Rafael Rodriguez Amado
- Laboratory of Drugs Discovery, Department of Biological Sciences and Health, Federal University of Amapá, Macapá, Brazil
| | - Gabriel Monteiro da Silva
- Bioinformatics Group, Department of Genetics, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil
| | - Irlon Maciel Ferreira
- Research Group Biocatalysis and Apllied Organic Synthesis, Federal University of Amapa, Macapá, Brazil
| | - Silvana Giuliatti
- Bioinformatics Group, Department of Genetics, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil
| | - José Carlos Tavares Carvalho
- Laboratory of Drugs Discovery, Department of Biological Sciences and Health, Federal University of Amapá, Macapá, Brazil
- Laboratory of Modeling and Computational Chemistry, Department of Biological Sciences and Health, Federal University of Amapa, Macapá, Brazil
- Research Group Biocatalysis and Apllied Organic Synthesis, Federal University of Amapa, Macapá, Brazil
| |
Collapse
|
9
|
Carvalho HO, Santos IVFD, Rocha CFD, Barros ASA, Faria e Souza BS, Ferreira IM, Bezerra RM, Lima CS, Castro AN, Carvalho JCT. Effect of the treatment of Copaifera duckei oleoresin (copaiba) in streptozotocin-induced diabetic rats. REVISTA BRASILEIRA DE FARMACOGNOSIA 2018. [DOI: 10.1016/j.bjp.2018.09.004] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
10
|
Kaur N, Kishore L, Singh R. Dillenia indica L. attenuates diabetic nephropathy via inhibition of advanced glycation end products accumulation in STZ-nicotinamide induced diabetic rats. J Tradit Complement Med 2017; 8:226-238. [PMID: 29322013 PMCID: PMC5756019 DOI: 10.1016/j.jtcme.2017.06.004] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2017] [Revised: 05/26/2017] [Accepted: 06/14/2017] [Indexed: 01/06/2023] Open
Abstract
The present study was aimed to evaluate advanced glycation end products (AGEs) inhibitory activity of alcohol and hydro-alcohol extract (DAE and DHE) of Dillenia indica L. (Family: Dilleniaceae) and its potential in treatment of diabetic nephropathy by targeting markers of oxidative stress. D. indica was evaluated for its in vitro inhibitory activity against formation of AGEs by using bovine serum albumin. Diabetes was induced in male Wistar rats by streptozotocin (65 mg/kg i.p.) 15 min after nicotinamide (230 mg/kg, i.p.) administration. Diabetic rats were treated with different doses of extracts (100, 200 and 400 mg/kg) to analyze their nephroprotective effect. Tissue antioxidant enzymes level was measured along with the formation of AGEs in kidney to assess the effect of D. indica in ameliorating oxidative stress. D. indica showed significant inhibition of AGEs formation in vitro. D. indica produced significant attenuation in the glycemic status, renal parameter, lipid profile and level of antioxidant enzymes proving efficacy in diabetic nephropathy. Moreover, D. indica produced significant reduction in the formation of AGEs in kidneys. The present study concludes that D. indica as a possible therapeutic agent against diabetic nephropathy.
Collapse
|
11
|
e Souza BSF, Carvalho HO, Ferreira IM, da Cunha EL, Barros AS, Taglialegna T, Carvalho JC. Effect of the treatment with Euterpe oleracea Mart. oil in rats with Triton-induced dyslipidemia. Biomed Pharmacother 2017; 90:542-547. [DOI: 10.1016/j.biopha.2017.04.005] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2016] [Revised: 03/24/2017] [Accepted: 04/02/2017] [Indexed: 12/27/2022] Open
|